ImmunityBio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	140.98	113.29	14.75	0.62	0.24	0.93
Revenue Growth (YoY)	351.53%	668.32%	2270.58%	159.17%	-74.30%	54.38%
Cost of Revenue	0.93	0.75	-	-	-	-
Gross Profit	140.04	112.54	14.75	0.62	0.24	0.93
Selling, General & Admin	163.12	150	168.78	129.62	102.71	135.26
Research & Development	238.31	218.56	190.14	232.37	248.15	195.96
Other Operating Expenses	-	-	-	0.89	0.68	-
Total Operating Expenses	401.43	368.56	358.93	362.87	351.54	331.21
Operating Income	-261.39	-256.03	-344.18	-362.25	-351.3	-330.28
Interest Income	7.83	6.41	7.98	1.13	-3.09	-4.1
Interest Expense	-97.28	-112.53	-154.33	-129.2	-63.52	-14.85
Other Non-Operating Income (Expense)	-487.15	10.54	76.89	-93.58	0.62	-0.61
Total Non-Operating Income (Expense)	-576.6	-95.58	-69.46	-221.64	-65.99	-19.56
Pretax Income	-854.5	-351.61	-413.65	-583.89	-417.29	-349.84
Provision for Income Taxes	0.11	-0.14	-	-0.04	0.03	0.01
Net Income	-854.53	-351.4	-413.56	-583.2	-416.57	-346.79
Minority Interest in Earnings	-0.07	-0.07	-0.08	-0.66	-0.75	-3.06
Net Income to Common	-854.53	-351.4	-413.56	-583.2	-416.57	-346.79
Shares Outstanding (Basic)	948	920	697	509	400	389
Shares Outstanding (Diluted)	948	920	700	509	400	389
Shares Change (YoY)	28.07%	31.33%	37.71%	27.19%	2.74%	3.23%
EPS (Basic)	-0.85	-0.38	-0.59	-1.15	-1.04	-0.89
EPS (Diluted)	-0.85	-0.38	-0.62	-1.15	-1.04	-0.89
Shares Outstanding	1,047	1,012	852.9	670.87	421.57	397.83
Free Cash Flow	-298.89	-308.78	-398.12	-397.34	-415.67	-307.98
Free Cash Flow Per Share	-0.32	-0.34	-0.57	-0.78	-1.04	-0.79
Gross Margin	99.34%	99.34%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-185.41%	-226.00%	-2334.23%	-58239.50%	-146374.00%	-35361.90%
Profit Margin	-606.20%	-310.25%	-2805.32%	-93866.90%	-173883.00%	-37457.00%
FCF Margin	-212.01%	-272.56%	-2700.06%	-63881.20%	-173196.00%	-32974.50%
EBITDA	-245.31	-240.5	-326.63	-343.74	-333.04	-316.04
EBITDA Margin	-174.01%	-212.29%	-2215.18%	-55263.30%	-138766.00%	-33837.50%
EBIT	-261.39	-256.03	-344.18	-362.25	-351.3	-330.28
EBIT Margin	-185.41%	-226.00%	-2334.23%	-58239.50%	-146374.00%	-35361.90%
Effective Tax Rate	-0.01%	0.04%	0.00%	0.01%	-0.01%	-0.00%

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q